CD40LG and neoplasm: To test if these L2pB1 cell-derived monoclonal IgM antibodies specifically recognize tumor cells but not normal, healthy growing cells, we tested the binding of L2pB1 cell-derived IgM antibodies on MC38 tumor spheroids or control MEF spheroids.